Patents by Inventor Nikolaus Gassler

Nikolaus Gassler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20120231065
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: February 2, 2012
    Publication date: September 13, 2012
    Applicant: SYGNIS BIOSCIENCE GmbH & Co. KG
    Inventors: WOLF-RUEDIGER SCHAEBITZ, ARMIN SCHNEIDER, CAROLA KRUEGER, CLEMENS SOMMER, STEFAN SCHWAB, RAINER KOLLMAR, MARTIN MAURER, DANIELA WEBER, NIKOLAUS GASSLER
  • Methods of treating neurological conditions with hematopoeitic growth factors
    Patent number: 8071543
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: December 6, 2011
    Assignee: Sygnis Bioscience GmbH & Co. KG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • Methods of treating neurological conditions with hematopoeitic growth factors
    Patent number: 8053407
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: November 8, 2011
    Assignee: Sygnis Bioscience GmbH & Co. KG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • Methods of treating neurological conditions with hematopoeitic growth factors
    Patent number: 7884069
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: February 8, 2011
    Assignee: Sygnis Bioscience GmbH & Co. KG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • Methods of treating neurological conditions with hematopoietic growth factors
    Patent number: 7785601
    Abstract: The present invention relates to a method of treating neurological conditions in a mammal by administering a hematopoietic growth factor such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The invention also provides methods of screening for compounds that bind to a GCSF or GMCSF receptor found on the surface of a neuronal cell; and which provides a neuroprotective, neuroproliferative and/or a STAT gene activation activity.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: August 31, 2010
    Assignee: Sygnis Bioscience GmbH & Co. KG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20100112038
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 6, 2010
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger SCHAEBITZ, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • Methods of treating neurological conditions with hematopoietic growth factors
    Patent number: 7695723
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: April 13, 2010
    Assignee: SYGNIS Bioscience GmbH & Co. KG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20090087481
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: April 2, 2009
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger SCHAEBITZ, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20080279814
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: August 29, 2007
    Publication date: November 13, 2008
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger SCHAEBITZ, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20080241097
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: October 2, 2008
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20080181865
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 31, 2008
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPEITIC GROWTH FACTORS
    Publication number: 20080175894
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 24, 2008
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS
    Publication number: 20080171080
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 17, 2008
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger SCHAEBITZ, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • Ee3-protein family and corresponding dna sequence
    Publication number: 20070157326
    Abstract: The present invention relates to (i) DNA sequences, (ii) expression vectors comprising DNA sequences of the invention, (iv) host cells having the expression vectors of the invention, (v) gene products encoded by sequences of the invention, (vi) transgenic animals altered with respect to sequences of the invention, (vii) antibodies directed against gene products of the invention, (viii) methods for expressing and/or isolating gene products of the invention, (ix) the use of DNA sequences and/or gene products of the invention as drugs, (x) pharmaceutically active compounds and methods for preparing them and also uses of such compounds of the invention and (xi) nontherapeutic uses of DNA sequences and/or gene products of the invention.
    Type: Application
    Filed: October 18, 2002
    Publication date: July 5, 2007
    Inventors: Armin Schneider, Martin Maurer, Wolfgang Kuschinsky, Sylvia Grunewald, Nikolaus Gassler
  • Methods of treating neurological conditions with hematopoeitic growth factors
    Publication number: 20050142102
    Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
    Type: Application
    Filed: June 30, 2004
    Publication date: June 30, 2005
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler
  • Methods of treating neurological conditions with hematopoietic growth factors
    Publication number: 20040141946
    Abstract: The present invention relates to a method of treating neurological conditions in a mammal by administering a hematopoietic growth factor such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The invention also provides methods of screening for compounds that bind to a GCSF or GMCSF receptor found on the surface of a neuronal cell; and which provides a neuroprotective, neuroproliferative and/or a STAT gene activation activity.
    Type: Application
    Filed: September 11, 2003
    Publication date: July 22, 2004
    Applicant: AXARON BIOSCIENCE AG
    Inventors: Wolf-Ruediger Schaebitz, Armin Schneider, Carola Krueger, Clemens Sommer, Stefan Schwab, Rainer Kollmar, Martin Maurer, Daniela Weber, Nikolaus Gassler